Protein Engineering Market By Technology (Irrational Protein Design, Rational Protein Design), By Protein (Coagulation Factor, Colony Stimulating Factor, Erythropoietin, Growth Hormones, Insulin, Interferon, Monoclonal Antibodies, Vaccines), By Product (Instruments, Reagents, Services & Software), By End Users (Academic Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), Industry Size, Growth, Share And Forecast To 2022
Key Findings
Growing prevalence of lifestyle oriented diseases across the globe and growing adoption of protein based drugs is driving the global protein engineeringmarket. Decrease in cost for drug discoveryhas a huge impact on the growth of global protein engineering market. Protein engineering is a rapidly growing market and had potentials of lucrative growth opportunity due to rising demand for amino acids and engineered proteins across the globe. Growing prevalence of life style oriented diseases such as blood pressure, diabetes, cardiac diseases and other chronic diseases has been expected to increase the demand for engineered proteins across the globe.According to WHO, there are about 9.4 million deaths occurs each year due to cardiac diseases across the globe out of which 9.4 million around 16.5% death are caused by blood pressure. In 2013, according to WHO there were about 235 million people sufferingfrom Asthma worldwide.Thus the rising prevalence of life style oriented diseases has been expected to stimulate the demand of protein engineering. Moreover, there are various initiative taken by various government across the globe in which North American and European government has established some favorable initiatives to support the protein engineering market. Also the technological advancement is one of the key factor driving the global market, as the increasing technological advancement is increasing the need for medicines that have higher specificity which has been expected to uplift the market during the forecasted period. Though the market has been growing rapidly but there are certain factors prevailing in the market such as high cost of protein engineering and need of high maintenance are restraining the market growth. Protein therapy is emerging as a substitute to gene therapy and rising number of off-patents of biological drugs are emerging as opportunity during the forecasted period in the global market.
Market Segment Insight
The global protein engineeringmarket is segmented on the basis of product, protein type, technology, end user and geography. On the basis of product, the market is segmented into instruments, reagents and services & software.The instruments segment holds the large market share of 42% in the product segment of protein engineering market. The end usersegment is segmented into academic research institutes, contract research organizations and pharmaceutical & biotechnology companies.The pharmaceuticals and biotechnology company dominates the segment with the large share followed by contract research organization. The protein type segment is also segmented intocoagulation factor, colony stimulating factor, erythropoietin, growth hormones, insulin, interferon, monoclonal antibodies, vaccines and others. Monoclonal antibodieshas been expected to hold the maximum markets share in the protein type segment and also anticipated to grow with the highest CAGR during the forecasted period. The technology is segmented into irrational protein design and rational protein design.
Regional Insight
Globally, the protein engineering market is segmented intoNorth America, Europe, APAC and ROW. North America region holds the largest market share in the global protein engineering market followed by Europe. The large market share of North American region is majorly driven by the growing prevalence of life style oriented diseases in the region, growing adoption of protein based drugs and rising healthcare expenditure in the North American region. Asia Pacific market has been expected to growth with an impulsive CAGR during the forecasted period. The impulsive growth is attributed by increasing population in emerging countries such as China and India, increasing disposable income in the region, growing prevalence of life style oriented diseases, rising incidences of chronic diseases and disorders, rising healthcare expenditure and development of healthcare infrastructure in the region. The rising demand for quality healthcare in the region is also driving the growth in the global market. The rising per capita income and escalating middle class population are also injecting huge growth opportunities in the Asia Pacific market. ROW market has been expected to see a balanced growth duringthe forecasted period of 2016-2022.
Competitive Insights
Some of the keymarket players are Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Eli Lilly and Company, General Electric, Johnson and Johnson, Sigma-Aldrich Corporation and Thermo Fisher Scientific.Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market.On 27th March 2015, Johnson & Johnson has announced its collaboration with Google for the purpose of advance surgical robots. This collaboration will help in benefiting patients, surgeons and healthcare systems.
CHAP 1. METHODOLOGY & SCOPE 11
1.1. RESEARCH METHODOLOGY 11
1.2. RESEARCH SCOPE & ASSUMPTIONS 11
1.3. LIST OF DATA SOURCES 11
CHAP 2. EXECUTIVE SUMMARY 12
2.1. GLOBAL PROTEIN ENGINEERING MARKET SUMMARY & KEY BUYING CRITERIA 12
2.2. GLOBAL PROTEIN ENGINEERING MARKET OUTLOOK 12
2.3. MARKET SEGMENTATION ANALYSIS 12
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 12
2.5. GLOBAL PROTEIN ENGINEERING MARKET VALUE CHAIN ANALYSIS 12
2.6. VENDOR LANDSCAPE 12
CHAP 3. GLOBAL PROTEIN ENGINEERING MARKET 13
3.1. MARKET DRIVER ANALYSIS 13
3.1.1. GROWING ADOPTION OF PROTEIN BASED DRUGS 13
3.1.2. DECREASE IN COST FOR DRUG DISCOVERY 13
3.1.3. GROWING PREVALENCE OF LIFESTYLE ORIENTED DISEASES 13
3.1.4. RISING FUNDING FOR PROTEIN ENGINEERING 13
3.2. MARKET RESTRAINT ANALYSIS 13
3.2.1. TOOLS USED IN PROTEIN ENGINEERING ARE EXPENSIVE AND NEED HIGH MAINTENANCE 13
3.3. KEY OPPORTUNITIES 13
3.3.1. GROWING EMERGING COUNTRIES 13
3.3.2. PROTEIN THERAPY IS EMERGING AS A SUBSTITUTE TO GENE THERAPY 13
3.3.3. RISING NUMBER OF OFF-PATENTS OF BIOLOGICAL DRUGS DURING FORECASTED PERIOD 13
3.4. CHALLENGES 13
3.4.1. LACK OF PROFESSIONAL AND QUALIFIED RESEARCHERS 13
3.4.2. HIGH TRAINING COST TO PROTEIN ENGINEERING 13
CHAP 4. INDUSTRY ANALYSIS 14
4.1. GLOBAL PROTEIN ENGINEERING MARKET– PORTER’S FIVE FORCE MODEL 14
4.2. GLOBAL PROTEIN ENGINEERING MARKET– PESTEL ANALYSIS 14
4.3. GLOBAL PROTEIN ENGINEERING MARKET– GAP ANALYSIS 14
CHAP 5. GLOBAL PROTEIN ENGINEERING MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 15
5.1. GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 2012-2022 ($ MILLION) 15
5.2. GLOBAL RATIONAL PROTEIN DESIGN MARKET 2012-2022 ($ MILLION) 15
CHAP 6. GLOBAL PROTEIN ENGINEERING MARKET BY PROTIEN TYPE 2012-2022 ($ MILLION) 16
6.1. GLOBAL COAGULATION FACTOR MARKET 2012-2022 ($ MILLION) 16
6.2. GLOBAL COLONY STIMULATING FACTOR MARKET 2012-2022 ($ MILLION) 16
6.3. GLOBAL ERYTHROPOIETIN MARKET 2012-2022 ($ MILLION) 16
6.4. GLOBAL GROWTH HORMONES MARKET 2012-2022 ($ MILLION) 16
6.5. GLOBAL INSULIN MARKET 2012-2022 ($ MILLION) 16
6.6. GLOBAL INTERFERON MARKET 2012-2022 ($ MILLION) 16
6.7. GLOBAL MONOCLONAL ANTIBODIES MARKET 2012-2022 ($ MILLION) 16
6.8. GLOBAL VACCINES MARKET 2012-2022 ($ MILLION) 16
CHAP 7. GLOBAL PROTEIN ENGINEERING MARKET BY PRODUCT 2012-2022 ($ MILLION) 17
7.1. GLOBAL INSTRUMENTS MARKET 2012-2022 ($ MILLION) 17
7.2. GLOBAL REAGENTS MARKET 2012-2022 ($ MILLION) 17
7.3. GLOBAL SERVICES & SOFTWARE MARKET 2012-2022 ($ MILLION) 17
CHAP 8. GLOBAL PROTEIN ENGINEERING MARKET BY END USERS 2012-2022 ($ MILLION) 18
8.1. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET 2012-2022 ($ MILLION) 18
8.2. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET 2012-2022 ($ MILLION) 18
8.3. GLOBAL PHARMCEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 2012-2022 ($ MILLION) 18
CHAP 9. GLOBAL PROTEIN ENGINEERING MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 19
9.1. GLOBAL PROTEIN ENGINEERING MARKET BY REGION 2012-2022 ($ MILLION) 19
9.2. NORTH AMERICA 19
9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
9.2.3.1. U.S. 19
9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
9.2.3.2. CANADA 19
9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
9.3. EUROPE 19
9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 19
9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 19
9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 19
9.3.3.1. GERMANY 19
9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
9.3.3.2. UK 20
9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
9.3.3.3. FRANCE 20
9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
9.3.3.4. RUSSIA 20
9.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 20
9.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 20
9.3.3.5. REST OF EUROPE 20
9.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 21
9.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 21
9.4. ASIA PACIFIC 21
9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 21
9.4.3.1. CHINA 21
9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
9.4.3.2. INDIA 21
9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 21
9.4.3.3. JAPAN 21
9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 21
9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 21
9.4.3.4. ROAPAC 21
9.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 22
9.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 22
9.5. REST OF THE WORLD 22
9.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
9.5.3.1. LATIN AMERICA 22
9.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.5.3.2. MIDDLE EAST AND AFRICA 22
9.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
CHAP 10. COMPETITIVE LANDSCAPE 23
10.1. AB SCIEX 24
10.1.1. COMPANY OVERVIEW 24
10.1.2. SCOT ANALYSIS 24
10.1.3. PRODUCT BENCHMARKING 24
10.1.4. STRATEGIC INITIATIVES 24
10.2. AGILENT TECHNOLOGIES, INC 24
10.2.1. COMPANY OVERVIEW 24
10.2.2. SCOT ANALYSIS 24
10.2.3. PRODUCT BENCHMARKING 24
10.2.4. STRATEGIC INITIATIVES 24
10.3. BIO-RAD LABORATORIES, INC 24
10.3.1. COMPANY OVERVIEW 24
10.3.2. SCOT ANALYSIS 24
10.3.3. PRODUCT BENCHMARKING 24
10.3.4. STRATEGIC INITIATIVES 24
10.4. BRUKER CORPORATION 24
10.4.1. COMPANY OVERVIEW 24
10.4.2. SCOT ANALYSIS 24
10.4.3. PRODUCT BENCHMARKING 24
10.4.4. STRATEGIC INITIATIVES 24
10.5. DANAHER CORPORATION 24
10.5.1. COMPANY OVERVIEW 24
10.5.2. SCOT ANALYSIS 24
10.5.3. PRODUCT BENCHMARKING 24
10.5.4. STRATEGIC INITIATIVES 24
10.6. ELI LILLY AND COMPANY 24
10.6.1. COMPANY OVERVIEW 24
10.6.2. SCOT ANALYSIS 25
10.6.3. PRODUCT BENCHMARKING 25
10.6.4. STRATEGIC INITIATIVES 25
10.7. GENENTECH INC. 25
10.7.1. COMPANY OVERVIEW 25
10.7.2. SCOT ANALYSIS 25
10.7.3. PRODUCT BENCHMARKING 25
10.7.4. STRATEGIC INITIATIVES 25
10.8. GENERAL ELECTRIC 25
10.8.1. COMPANY OVERVIEW 25
10.8.2. SCOT ANALYSIS 25
10.8.3. PRODUCT BENCHMARKING 25
10.8.4. STRATEGIC INITIATIVES 25
10.9. GENSCRIPTS INC. 25
10.9.1. COMPANY OVERVIEW 25
10.9.2. SCOT ANALYSIS 25
10.9.3. PRODUCT BENCHMARKING 25
10.9.4. STRATEGIC INITIATIVES 25
10.10. JOHNSON AND JOHNSON 25
10.10.1. COMPANY OVERVIEW 25
10.10.2. SCOT ANALYSIS 25
10.10.3. PRODUCT BENCHMARKING 25
10.10.4. STRATEGIC INITIATIVES 25
10.11. NOVO NORDISK 25
10.11.1. COMPANY OVERVIEW 25
10.11.2. SCOT ANALYSIS 25
10.11.3. PRODUCT BENCHMARKING 25
10.11.4. STRATEGIC INITIATIVES 25
10.12. PERKINELMER, INC 26
10.12.1. COMPANY OVERVIEW 26
10.12.2. SCOT ANALYSIS 26
10.12.3. PRODUCT BENCHMARKING 26
10.12.4. STRATEGIC INITIATIVES 26
10.13. SIGMA-ALDRICH CORPORATION 26
10.13.1. COMPANY OVERVIEW 26
10.13.2. SCOT ANALYSIS 26
10.13.3. PRODUCT BENCHMARKING 26
10.13.4. STRATEGIC INITIATIVES 26
10.14. THERMO FISHER SCIENTIFIC 26
10.14.1. COMPANY OVERVIEW 26
10.14.2. SCOT ANALYSIS 26
10.14.3. PRODUCT BENCHMARKING 26
10.14.4. STRATEGIC INITIATIVES 26
10.15. WATERS CORPORATION 26
10.15.1. COMPANY OVERVIEW 26
10.15.2. SCOT ANALYSIS 26
10.15.3. PRODUCT BENCHMARKING 26
10.15.4. STRATEGIC INITIATIVES 26
TABLE 1 GLOBAL PROTEIN ENGINEERING MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 27
TABLE 2 GLOBAL IRRATIONAL PROTEIN DESIGN MARKET 2012-2022 ($ MILLION) 27
TABLE 3 GLOBAL RATIONAL PROTEIN DESIGN MARKET 2012-2022 ($ MILLION) 27
TABLE 4 GLOBAL PROTEIN ENGINEERING MARKET BY PROTIEN TYPE 2012-2022 ($ MILLION) 28
TABLE 5 GLOBAL COAGULATION FACTOR MARKET 2012-2022 ($ MILLION) 28
TABLE 6 GLOBAL COLONY STIMULATING FACTOR MARKET 2012-2022 ($ MILLION) 28
TABLE 7 GLOBAL ERYTHROPOIETIN MARKET 2012-2022 ($ MILLION) 28
TABLE 8 GLOBAL GROWTH HORMONES MARKET 2012-2022 ($ MILLION) 28
TABLE 9 GLOBAL INSULIN MARKET 2012-2022 ($ MILLION) 28
TABLE 10 GLOBAL INTERFERON MARKET 2012-2022 ($ MILLION) 28
TABLE 11 GLOBAL MONOCLONAL ANTIBODIES MARKET 2012-2022 ($ MILLION) 28
TABLE 12 GLOBAL VACCINES MARKET 2012-2022 ($ MILLION) 28
TABLE 13 GLOBAL PROTEIN ENGINEERING MARKET BY PRODUCT 2012-2022 ($ MILLION) 28
TABLE 14 GLOBAL INSTRUMENTS MARKET 2012-2022 ($ MILLION) 28
TABLE 15 GLOBAL REAGENTS MARKET 2012-2022 ($ MILLION) 28
TABLE 16 GLOBAL SERVICES & SOFTWARE MARKET 2012-2022 ($ MILLION) 28
TABLE 17 GLOBAL PROTEIN ENGINEERING MARKET BY END USER 2012-2022 ($ MILLION) 28
TABLE 18 GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET 2012-2022 ($ MILLION) 28
TABLE 19 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET 2012-2022 ($ MILLION) 28
TABLE 20 GLOBAL PHARMCEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 2012-2022 ($ MILLION) 28
TABLE 21 NORTH AMERICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 28
TABLE 22 NORTH AMERICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 28
TABLE 23 NORTH AMERICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 28
TABLE 24 U.S. GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 25 U.S. GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 26 CANADA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 27 CANADA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 29
TABLE 28 CANADA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 29 EUROPE GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 30 EUROPE GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 31 EUROPE GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 29
TABLE 32 GERMANY GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 33 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 34 UK GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 35 UK GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 36 ASIA PACIFIC GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 37 ASIA PACIFIC GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 38 ASIA PACIFIC GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 29
TABLE 39 CHINA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 29
TABLE 40 CHINA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 29
TABLE 41 INDIA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 42 INDIA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 43 JAPAN GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 44 JAPAN GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 45 MIDDLE EAST & AFRICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 46 MIDDLE EAST & AFRICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
TABLE 47 LATIN AMERICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 30
TABLE 48 LATIN AMERICA GLOBAL PROTEIN ENGINEERING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 30
FIGURE 1 MARKET SHARE BY REGIONS 2012-2022 ($ MILLION) 30
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 30
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 13 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
FIGURE 14 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)